Yahoo
OTC Markets OTCPK - Delayed Quote USD

Khiron Life Sciences Corp. (KHRNF)

0.0000 0.0000 (0.00%)
At close: October 29 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for KHRNF
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0000
  • Volume 15,039
  • Avg. Volume 0
  • Market Cap (intraday) 2,324
  • Beta (5Y Monthly) 20.72
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Khiron Life Sciences Corp. operates as a medical cannabis company in Latin America and Europe. It engages in the cultivation, production, distribution, and export of tetrahydrocannabinol medical cannabis products. The company is also involved in the operation of health centers under the Zerenia and Dr. Zerenia brand names; and provision of medical education and training programs for health professionals. It sells its products in Colombia, Peru, Germany, the United Kingdom, Brazil, Uruguay, and Mexico. The company is headquartered in Bogota, Colombia.

khiron.ca

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

KHRNF
0.00%
S&P 500 (^GSPC)
10.73%

1-Year Return

KHRNF
0.00%
S&P 500 (^GSPC)
11.11%

3-Year Return

KHRNF
99.91%
S&P 500 (^GSPC)
81.91%

5-Year Return

KHRNF
100.00%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY22
Revenue 3.38M
Earnings --
Profit Margin 0.00%

Q4

FY21

Q1

FY22

Q2

FY22

Q3

FY22

0
1M
2M
3M
4M
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -190.00%

  • Return on Assets (ttm)

    -20.79%

  • Return on Equity (ttm)

    -74.68%

  • Revenue (ttm)

    16.14M

  • Net Income Avi to Common (ttm)

    -30.66M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.94M

  • Total Debt/Equity (mrq)

    9.46%

  • Levered Free Cash Flow (ttm)

    -8.83M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: